US-based clinical research organisation (CRO) Catalyst Clinical Research announced on Thursday that it has named Kristin Judge is its first chief commercial officer (CCO).

In the new role, Judge is to head the firm's commercial functions.

Judge has served in strategic roles at Emmes, Veeva Systems, Labcorp Drug Development, and PPD. She has over 17 years of experience and has led inside sales, marketing, sales operations and has been a key member in various acquisitions and integrations.

Nik Morton, Catalyst Clinical Research president and CEO, said, 'Kristin has the depth of commercial experience to support Catalyst's continued growth. Her experience supporting biotech, and pharmaceutical customers with CRO services and life-sciences technologies will be invaluable. She has embraced Catalyst's culture and vision for a differentiated CRO, and will ensure our commercial team is best positioned to deliver strengthened sales performance and continued growth.'